Clinic audit on Chronic Obstructive Pulmonary Disease (COPD) management in public primary care setting: Hong Kong experience

Background

Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by a persistent reduction of airflow resulting from chronic inflammation in the lung and remodeling of small airways (1). According to The Global Burden of Disease Study, there were 251 million COPD cases in 2016 around the world and around 3.2 million people died from COPD in 2015 (2). In Hong Kong (HK), the Population Health Survey 2014/15 reported that 0.5% of non-institutionalized persons aged 15 and above had doctor-diagnosed COPD (3). The disease accounted for over 30,000 episodes of inpatient discharges and deaths in 2016 and 1,223 registered deaths in 2017 (4). Therefore, COPD imposed a substantial economic and social burden to the health care system.

COPD is a commonly encountered condition in primary care. Primary care professionals have an essential role in taking comprehensive measures to improve the disease control and prevent its acute exacerbation. For example, large amount of evidence in the literature have shown that smoking cessation is the most effective intervention to slow down the disease progression of COPD (5). In addition, early diagnosis with spirometry test and implementation of influenza and pneumococcal vaccination have all been shown to reduce the disease burden and improve COPD patients’ quality of life (6-8). Despite all these evidences, the management of COPD is still far from satisfactory. For example, Kester et al. found that only 5% of Canadian general practitioners requested a pulmonary function test when attending an individual with clear signs of COPD (9). It is also disappointing to note that the referral rate and attendance rate for smoking cessation counselling service among COPD smokers remained low (10,11) and therefore their smoking cessation rate had been much poorer than those without COPD. Furthermore, the low take-up rate of seasonal influenza vaccine at 20–60% (12-15) will render this vulnerable group of patients a higher risk of developing chest infection during the winter surge. If all these preventive measures are not effectively implemented, acute exacerbation of COPD (AECOPD) would be inevitable. Indeed, acute exacerbations have been proven to lead to accelerated decline in lung function, increased COPD-related hospitalizations and mortality, and lastly augmented the health care utilization (16).

In HK, about 80% of COPD patients are managed under specialist care and 20% are managed at primary care clinics under the Hospital Authority of Hong Kong (HAHK) (17). A pilot survey conducted in 2011 found that COPD care at both primary and secondary level in HAHK needed to be improved (18). For example, spirometry was underused in the diagnosis and monitoring of patients with COPD (19) and a suboptimal adherence to accredited COPD management guideline was identified at five tertiary respiratory centers from 2013 to 2015 (20). Insufficient patient education, suboptimal coding of lung function results, underutilization of long-acting bronchodilators and lack of an integrative management model were the main issues to be tackled (21). In view of this, starting from 1 April, 2017, COPD audit had been conducted across all primary care clinics of HAHK to review the performance of COPD care so as to improve its clinical outcome. This study aimed to audit the management of COPD cases from all primary care clinics of HAHK and to work out improvement strategies. We believe that by improving the standard of care to COPD patients managed in the community via the aligned audit approach, the disease burden including the number of hospital admissions due to AECOPD would be greatly reduced.

Method

Results

Table 3 summarizes the demographic characteristics of COPD patients included into the two phases. Their age, gender and smoking status were comparable. Around 88% of the COPD patients in both phases were male and the majority were elderly patients aged over 65 years old. Approximately 30% of COPD patient were chronic smokers.

Among the 10,385 patients reviewed in Phase 1, 1,144 cases (11.0%) were referred to specialists for continued care. Among the 9,153 patients included in Phase 2, 6,088 patients were FU cases from Phase 1, with a case overlapping rate of 64.0%. At the end of the Phase 2, 1,057 cases (11.1%) were referred to specialists for further care. The SOPD referral rate was also comparable between the two phases (P=0.83).

A comparison of the standards achieved in the two phases is summarized in Table 4. In the first phase, marked deficiencies were identified in almost all criteria. It is quite alarming to note that less than one fifth of COPD patients (19.1%) had performed spirometry before. 1,327 cases (12.8%) had at least one episode of hospital admission due to AECOPD. After proactive execution of the enhancement strategies during the implementation phase, significant improvement was observed with respect to all criteria in Phase 2. The most clinically important change was observed in the hospital admission rate due to AECOPD, reducing to 910 (9.6%) in Phase 2 (P<0.00001). Further analysis on the frequencies of hospital admissions due to AECOPD revealed that the reduction had been significant for all frequencies including being admitted once, twice, and three times or more between the two phases (P<0.00001).

Further comparisons on the hospital admission rate due to AECOPD revealed that the reduction was only significant among the elderly age groups (from 14.1% in phase 1 to 10.5% in phase 2, P<0.00001), whereas the improvement in the younger age group was not significant (P=0.2) (Figure 1).

• Download figure
• Open in new tab

Figure 1. Comparison of hospital admission rate due to AECOPD among different age groups between the two phases.

Discussion

Marked deficiencies existed in various aspects of COPD management in the primary care setting in phase 1. This is an expected albeit disappointing finding due to the service gaps at different levels such as knowledge set, skill set and tool set. These were particularly apparent in the process criteria such as smoking cessation service referral, uptake rate of SIV or PCV, and under-utilization of spirometry test. Through the concerted effort paid during the audit process, COPD management at all public primary care clinics in HK had been greatly enhanced, with all audit criteria being tremendously improved and target audit standard achieved. The outcome criteria, AECOPD rate leading to hospital admission, was also significantly reduced in Phase 2.

It is of note that the overall headcounts of COPD patients under the care of HAHK had been decreasing over the years. In view of the comparable annual overall mortality rate (3.8% in phase 1 versus 3.5% in phase 2, P=0.22) and SOPD referral rate (11.0% in phase 1 versus 11.1% in phase 2, P=0.83) between the two phases, we believe that the reduction in the total case number of COPD was likely due to the decreased prevalence of COPD in HK although the exact data is still lacking. Indeed, an overview on the prevalence and incidence of chronic respiratory disease published early this year showed that the incidence rate of COPD decreased in all age groups from 1990 to 2017 globally, except for elderly patients older than 80 years (24). This reduced prevalence could partially be explained by the fact that the prevalence of daily cigarette smokers of HK dropped to 10.0% in 2017, which is the lowest rate recorded since 1982 according to the Thematic Household Survey released by Census and Statistics Department of HK (25).

About 20% of COPD patients were found not to have a prescheduled FU for regular assessment at the beginning of the audit. Currently there is no cure for COPD, but treatment can help control the symptoms and slowdown its progression, therefore warranting a regular FU to assess its severity. On the one hand, all doctors were reminded to arrange an FU appointment for all COPD cases during their routine consultation. On the other, the audit team had gone through the COPD case registry who had no FU appointment in the CMS to review whether they had been arranged to have any FUs with private doctors or respiratory specialists. Some were called up individually by nursing staff to enquire about their symptom control. A FU appointment would be offered if the patient had not received proper assessment in the recent one year. With such effort, many lost-to-FU COPD cases returned to GOPCs for spirometry and clinical assessment, with 87.7% of all COPD cases having regular FU in GOPCs in Phase 2 (P<0.00001).

Smoking leads to COPD in more than 80% of cases and smoking cessation is the most effective intervention in stopping the progression of COPD, as well as increasing the survival and reducing the morbidity (26). In view of this, evidence based approach using a combination of behavioral and pharmaceutical interventions had been adopted at the SCCS in HAHK since 2010. As a routine practice, all primary care doctors refer COPD smokers to the SCCS during the consultation. However, evidence-practice gap did exist and it is not surprising to find that only about half of COPD smokers were referred and even fewer actually attended the SCCS in Phase 1. These findings were consistent with literature suggesting that COPD smokers are poorly motivated to quit smoking in general (10). Another possibility is the physician-related factor. For example, literature shows that some physicians do not routinely deal with smoking cessation during their consultations with smokers partly due to lack of cessation specific knowledge or skills and partly due to insufficient consultation time (27). This is particularly true in HK where the average time allocated for each consultation is only about 7 minutes at GOPCs. To address this service gap, a series of training programs on smoking cessation counseling and motivational interview had been organized to strengthen staff’s knowledge and skill on smoking cessation. Besides, the SCCS workflow had been revamped in some clusters so that the counselling could be delivered in the same session once referred, which resulted in a significantly reduced default rate. With the concerted effort and cohesive support from the smoking cessation nurse, the situation at Phase 2 had been significantly improved with the target standard achieved.

For criteria 3 and 4 on the update rate of SIV and PCV, although our performance had significantly improved during the audit cycle, only more than half of COPD patients were vaccinated against SIV (57.0%%) and PCV (59.6%) in Phase 2. Indeed, influenza vaccination coverage rates among COPD patients remain low in many countries (13-14). In HK, all elderly patients aged over 65 years are entitled to receive SIV and PCV for free under the HK Government Vaccination Program. However, the breakdown figures of SIV coverage among those under age 65 were still far from satisfactory (6.7% in Phase 1 and 8.9% in Phase 2). Given the widely established evidence on the long-term benefits of SIV on COPD care, such as reduced number of exacerbations, hospitalizations and all-cause mortalities (7), we would like to propose that HK government should launch out free SIV to COPD patients of all ages to reduce the mortality.

It is alarming to find that only 19.1% COPD patients had spirometry test before in Phase 1. This was consistent with local studies done in 2013 showing that spirometry had been underused in general but especially by family physicians in the management of COPD patients, with only 18.3% patient had spirometry done during diagnostic workup (19).

The reasons accounting for this poor performance rate are multifactorial. At doctors’ level, some doctors often make the diagnosis of COPD based on clinical features alone. At clinic level, spirometry service was previously only available at hospital setting. Therefore, suspected COPD patients had to be referred to Respiratory Specialist Clinic to perform the lung function tests where the waiting time ranged from months to two years under HAHK. To plug this loophole, a series of education talks on the proper diagnosis and management of COPD, emphasizing on the importance of spirometry test, were delivered to all doctors. Furthermore, some selected GOPCs were equipped with spirometry machine during the implementation phase so that the spirometry test could be conveniently performed locally within 2-4 weeks. In addition, at least 1-2 designated nurses from these GOPCs had been specially trained on how to perform the spirometry correctly based on the aligned standard. With such facilitations both on the skill set and tool set, tremendous improvement was observed for this criteria in Phase 2 (64.5%, P<0.00001).

The last criteria 6, the rate of AECOPD leading to hospital admission, is the single most important outcome criteria of this audit. Mild to moderate AECOPD that had been well managed in GOPCs would not be included in this criteria. In Phase 1, almost 1 in 8 of COPD patient (12.8%) had been admitted to hospital due to AECOPD. This rate was lower than those reported in the literature which showed around 20% of COPD patients had experienced severe acute exacerbations leading to hospital admission annually (28, 29). This discrepancy might be explained by the fact that majority of COPD cases managed in primary care clinics belong to the mild grade (Group A and B) according to GOLD guideline. Indeed, local data from Kowloon Center Cluster of HAHK has confirmed that only about 10% of COPD cases FU in primary care clinics belonged to Group C and D (30). In order to further decrease the burden of hospital admissions, prevention and prompt treatment of exacerbations are the key goals in COPD care. With such mindset, a series of service enhancement strategies were executed. Firstly, early identification of COPD patients by spirometry and proper grading according to the GOLD guideline were done as mentioned above. Secondly, all COPD cases were managed according to their grading, hence providing the right level of care to the right patients. For example, stable Group A/B patients would continue regular FU at GOPCs, where long acting anti-muscarinic antagonist (LAMA) was newly introduced in 2018 in some clusters to improve the symptom control. For more severe Group C/D patients that warrant advanced care, a timely referral to the Respiratory Specialists would be initiated. Lastly, relatively stable AECOPD patients had been managed locally with more frequent FU instead of being admitted to hospital, hence reducing the hospital burden. This is in line with findings in the literature that frequent outpatient visits prevent the exacerbation of COPD (31). With all these proactive interventions and efforts, the AECOPD rate leading to hospital admission was significantly reduced to 9.6% in Phase 2. In addition, the reduction was significant for COPD patients admitted to hospital at all frequencies, proving that our strategies were effective for COPD patients of different severities.

Conclusion

COPD management at all primary care clinics of HAHK had been significantly enhanced during the past three years. Via a team approach with streamlined governance and structure as well as proactive staff engagement, marked improvement had been achieved in all audit criteria for COPD management. The significant reduction in AECOPD rate will help relieve the burden to specialist care and hospital in the long run.

Data sharing statement

The datasets used in the current study were compiled by the Statistical Team from the Head Office of HAHK and are used as internal reference only. They would be available from the corresponding author on reasonable request after being approved by Head Office of HAHK.